Literature DB >> 1326889

Intravenous enalaprilat and oral enalapril in congestive heart failure secondary to ventricular septal defect in infancy.

T Sluysmans1, M Styns-Cailteux, M Tremouroux-Wattiez, P A de Lame, J Lintermans, J Rubay, A Vliers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1326889     DOI： 10.1016/0002-9149(92)90749-o

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  5 in total

1.  Ventricular Septal Defect.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  1999-12

Review 2.  Does digoxin still have a role in congestive heart failure?

Authors:  S S Kothari
Journal:  Indian J Pediatr       Date:  1997 Nov-Dec       Impact factor: 1.967

Review 3.  ACE inhibitors in pediatric patients with heart failure.

Authors:  Kazuo Momma
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

4.  Enalapril-induced acute renal failure in a newborn infant.

Authors:  Sourabh Dutta; Anil Narang
Journal:  Pediatr Nephrol       Date:  2003-04-16       Impact factor: 3.714

5.  Efficacy and dosage of enalapril in congenital and acquired heart disease.

Authors:  A M Leversha; N J Wilson; P M Clarkson; A L Calder; M C Ramage; J M Neutze
Journal:  Arch Dis Child       Date:  1994-01       Impact factor: 3.791
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.